Monday, June 05, 2006

New drug extends lung cancer survival 22 percent

With bortezomib plus standard care, patients with advanced lung cancer lived 11 months

read more | digg story

1 Comments:

Anonymous Anonymous said...

Super color scheme, I like it! Good job. Go on.
»

7:27 AM  

Post a Comment

<< Home